Agnieszka Czarniecka

Agnieszka Czarniecka

UNVERIFIED PROFILE

Are you Agnieszka Czarniecka?   Register this Author

Register author
Agnieszka Czarniecka

Agnieszka Czarniecka

Publications by authors named "Agnieszka Czarniecka"

Are you Agnieszka Czarniecka?   Register this Author

49Publications

1606Reads

14Profile Views

Surgical approach to differentiated thyroid cancers (DTC) in children [Specyfika leczenia chirurgicznego zróżnicowanych raków tarczycy (ZRT) u dzieci].

Endokrynol Pol 2019 ;70(4):357-366

Department of Nuclear Medicine and Endocrine Oncology, M. Sklodowska-Curie Institute - Oncology Centre, Gliwice, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/EP.a2019.0033DOI Listing
February 2020

Current surgical management in RET mutation carriers [Aktualne postępowanie chirurgiczne u nosicieli mutacji proto-onkogenu RET].

Endokrynol Pol 2019 ;70(4):367-379

Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute - Oncology Centre Gliwice Branch, Gliwice, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/EP.a2019.0021DOI Listing
February 2020

European perspective on the use of molecular tests in the diagnosis and therapy of thyroid neoplasms.

Gland Surg 2020 Feb;9(Suppl 2):S69-S76

The Oncologic and Reconstructive Surgery Clinic, Maria Sklodowska-Curie Institute-Oncology Center, Gliwice Branch, Gliwice, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/gs.2019.10.26DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044080PMC
February 2020

Clinical validation of S-Detect mode in semi-automated ultrasound classification of thyroid lesions in surgical office.

Gland Surg 2020 Feb;9(Suppl 2):S77-S85

Department of Endocrine Surgery, Third Chair of General Surgery, Jagiellonian University Medical College, Kraków, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/gs.2019.12.23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044084PMC
February 2020

BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.

Eur J Cancer 2020 Jan 29;124:161-169. Epub 2019 Nov 29.

Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.10.017DOI Listing
January 2020

Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma.

Genes Chromosomes Cancer 2019 08 18;58(8):558-566. Epub 2019 Feb 18.

Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute - Oncology Center Gliwice Branch, Gliwice, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22737DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594006PMC
August 2019

Heterogeneity of Thyroid Cancer.

Pathobiology 2018 6;85(1-2):117-129. Epub 2018 Feb 6.

Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000486422DOI Listing
October 2018

BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer.

J Clin Oncol 2018 09 2;36(27):2787-2795. Epub 2018 Aug 2.

Fei Wang, Shihua Zhao, and Yangang Wang, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China; Fei Wang, Xiaopei Shen, Guangwu Zhu, Rengyun Liu, and Mingzhao Xing, Johns Hopkins University School of Medicine, Baltimore, MD; David Viola and Rossella Elisei, University of Pisa, Pisa; Efisio Puxeddu, University of Perugia, Perugia; Laura Fugazzola and Carla Colombo, Istituto Auxologico Italiano, Istituto di Recovero e Cura a Carattere Scientifico (IRCCS), and University of Milan, Milan; Caterina Mian, University of Padua; Federica Vianello, Veneto Institute of Oncology, IRCCS, Padua, Italy; Barbara Jarzab and Agnieszka Czarniecka, Maria Sklodowska-Curie Institute Oncology Center, Gliwice, Poland; Alfred K. Lam, Griffith University, Gold Coast, Queensland; Christine J. O'Neill, Mark S. Sywak, and Roderick Clifton-Bligh, University of Sydney, Sydney, New South Wales, Australia; Linwah Yip, University of Pittsburgh, Pittsburgh, PA; Garcilaso Riesco-Eizaguirre, Hospital Universitario La Paz and Hospital Universitario de Móstoles; Garcilaso Riesco-Eizaguirre and Pilar Santisteban, Biomedical Research Institute "Alberto Sols" and Health Institute Carlos III, Madrid, Spain; and Bela Bendlova and Vlasta Sýkorová, Institute of Endocrinology, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.5097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145834PMC
September 2018

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update.

Endokrynol Pol 2018 ;69(1):34-74

Nuclear Medicine and Endocrine Oncology Department; M.Sklodowska-Curie Memorial Institute - Cancer Center, Gliwice Branch, Wybrzeze AK 15, 44-100 Gliwice, Poland; Zakład Medycyny Nuklearnej i Endokrynologii Onkologicznej, Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach, Wybrzeże AK 15, 44-100 Gliwice, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/EP.2018.0014DOI Listing
July 2018

Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer.

J Clin Oncol 2018 02 14;36(5):438-445. Epub 2017 Dec 14.

Xiaopei Shen, Guangwu Zhu, Rengyun Liu, and Mingzhao Xing, Johns Hopkins University School of Medicine, Baltimore, MD; David Viola and Rossella Elisei, University of Pisa, Pisa; Efisio Puxeddu, University of Perugia, Perugia; Laura Fugazzola and Carla Colombo, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Auxologico Italiano and University of Milan, Milan; Caterina Mian, University of Padua; Federica Vianello, Veneto Institute of Oncology, IRCCS, Padua, Italy; Barbara Jarzab and Agnieszka Czarniecka, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Alfred K. Lam, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland; Christine J. O'Neill, Mark S. Sywak, and Roderick Clifton-Bligh, The University of Sydney, Sydney, New South Wales, Australia; Linwah Yip, University of Pittsburgh School of Medicine, Pittsburgh, PA; Garcilaso Riesco-Eizaguirre, Hospital Universitario La Paz and Hospital Universitario de Móstoles; Garcilaso Riesco-Eizaguirre and Pilar Santisteban, Biomedical Research Institute "Alberto Sols," Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid; Garcilaso Riesco-Eizaguirre and Pilar Santisteban, Ciberonc, Health Institute Carlos III, Madrid, Spain; and Bela Bendlova and Vlasta Sýkorová, Institute of Endocrinology, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.5497DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807010PMC
February 2018

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?

Int J Mol Sci 2017 Aug 22;18(8). Epub 2017 Aug 22.

Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Institute-Cancer Center, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101 Gliwice, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms18081817DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578203PMC
August 2017

The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study.

Endokrynol Pol 2015 ;66(2):121-5

Department of Nuclear Medicine and Endocrine Oncology Maria Sklodowska-Curie memorial Cancer Center and Institute of Oncology in Warsaw, Gliwice Branch.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/EP.2015.0018DOI Listing
February 2017

mutation in prognostication of papillary thyroid cancer (PTC) recurrence.

Gland Surg 2016 Oct;5(5):495-505

Department of Endocrine Surgery, Third Chair of General Surgery, Jagiellonian University, Medical College, Kraków, Poland.

View Article

Download full-text PDF

Source
http://gs.amegroups.com/article/view/11915/12489
Publisher Site
http://dx.doi.org/10.21037/gs.2016.09.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106385PMC
October 2016

Somatic mutation profiling of follicular thyroid cancer by next generation sequencing.

Mol Cell Endocrinol 2016 09 6;433:130-7. Epub 2016 Jun 6.

Department of Nuclear Medicine and Endocrine Oncology, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland; Laboratory of Molecular Neurobiology, Neurobiology Center, Nencki Institute of Experimental Biology, Warsaw, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mce.2016.06.007DOI Listing
September 2016

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

J Clin Endocrinol Metab 2016 Jan 3;101(1):264-74. Epub 2015 Nov 3.

Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes & Metabolism, Department of Medicine (X.Shi., R.L., X.Shen., D.T., M.X.), Johns Hopkins University School of Medicine, Baltimore, MD 21287; Department of Surgery, Division of Pathology (F.B., R.G.), 56126 Pisa, Italy; The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, Department of Endocrinology and Metabolism (H.G., Z.S., W.T.), The First Hospital of China Medical University, Shenyang, Liaoning Province 110001, China; Endocrine Surgery (T.J.M.), University Medical Center, Johannes Gutenberg University Mainz, 55101 Mainz, Germany; Human Cancer Genomic Research (K.A.K.), Research Centre, King Faisal Specialist Hospital and Research Centre, Riyadh 12713, Kingdom of Saudi Arabia; Fondazione Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Policlinico, Milan, and Department of Pathophysiology and Transplantation (L.E., C.C.), University of Milan, 20122 Milan Italy; Endocrine Oncology Branch, Center for Cancer Research (E.K.), National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (A.C., B.J.), 44-101 Gliwice, Poland; Department of Molecular Endocrinology (B.B., V.S.), Institute of Endocrinology, Prague 11694, Czech Republic; Institute of Molecular Pathology and Immunology (Manuel Sobrinho-Simões, M.S.S.; Paula Soares, P.So.), University of Porto (Ipatimup) and Medical Faculty of the University of Porto, 4200-319 Porto, Portugal; College of Medicine (Y.K.S., T.Y.K.), University of Ulsan College of Medicine, Seoul, South Korea; Department of Pathology (S.C.; S.L.A.), University Health Network, Toronto, ON M5G 2C4 Canada; Endocrine Unit, Department of Clinical and Experimental Medicine (D.V., R.E.), World Health Organization, Collaborating Center for the Study and Treatment of Thyroid Diseases and Other Endocrine and Meta

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2015-2917DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701842PMC
January 2016

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

J Clin Oncol 2015 Jan 20;33(1):42-50. Epub 2014 Oct 20.

Mingzhao Xing and Ali S. Alzahrani, Johns Hopkins University School of Medicine; Kathryn A. Carson, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD; Young Kee Shong and Tae Yong Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; David Viola and Rossella Elisei, WHO Collaborating Center for the Study and Treatment of Thyroid Diseases and Other Endocrine and Metabolic Disorders, University of Pisa, Pisa; Caterina Mian, University of Padua; Federica Vianello, Veneto Institute of Oncology, Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua; Efisio Puxeddu, University of Perugia, Perugia; Laura Fugazzola, University of Milan and Fondazione IRCCS CàGranda, Milan; Giovanni Tallini, University of Bologna School of Medicine, Bellaria Hospital, Bologna, Italy; Bela Bendlová and Vlasta Sýkorová, Institute of Endocrinology, Prague, Czech Republic; Linwah Yip, University of Pittsburgh School of Medicine, Pittsburgh, PA; R. Michael Tuttle, Eyal Robenshtok, and James A. Fagin, Memorial Sloan-Kettering Cancer Center, New York, NY; Agnieszka Czarniecka and Barbara Jarzab, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christine J. O'Neill, Mark S. Sywak, and Roderick Clifton-Bligh, University of Sydney, Sydney, New South Wales; Alfred K. Lam, Griffith University School of Medicine, Gold Coast, Queensland, Australia; Garcilaso Riesco-Eizaguirre, Hospital La Paz, Health Research Institute, and Hospital Universitario de Móstoles; Garcilaso Riesco-Eizaguirre and Pilar Santisteban, Biomedical Research Institute Alberto Sols, Spanish Council of Research, and Autonomous University of Madrid, Madrid, Spain; Hirotaka Nakayama, Kanagawa Cancer Center, Yokohama, Japan; and Elizabeth H. Holt, Yale University School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/10/14/JCO.2014.56
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.56.8253
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.8253DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268252PMC
January 2015

Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers - the role of Ct serum level.

Thyroid Res 2013 Mar 14;6 Suppl 1:S9. Epub 2013 Mar 14.

Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101 Gliwice, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-6614-6-S1-S9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599705PMC
March 2013

Occurrence of BRAF mutations in a Polish cohort of PTC patients - preliminary results.

Endokrynol Pol 2010 Sep-Oct;61(5):462-6

Department of Oncological and Reconstructive Surgery, MSC Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Poland.

View Article

Download full-text PDF

Source
http://www.researchgate.net/profile/Jolanta_Krajewska/public
Web Search
August 2011

Has differentiated thyroid cancer (DTC) staging changed with in the last ten years in the Silesia region of Poland?

Endokrynol Pol 2010 Sep-Oct;61(5):480-4

Department of Nuclear Medicine and Endocrine Oncolgy, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Poland.

View Article

Download full-text PDF

Source
August 2011

[Diagnosis and treatment of thyroid cancer - Polish guidelines].

Endokrynol Pol 2010 Sep-Oct;61(5):518-68

Polskie Towarzystwo Endokrynologiczne.

View Article

Download full-text PDF

Source
August 2011

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions.

Mol Cell Endocrinol 2010 Jun 4;322(1-2):8-28. Epub 2010 Feb 4.

Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 14, 44-100 Gliwice, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mce.2010.01.007DOI Listing
June 2010

[Hypoparathyroidism after surgery on thyroid cancer: is there a delayed chance for recovery after a prolonged period of substitutive therapy?].

Endokrynol Pol 2006 Sep-Oct;57(5):501-8

Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska-Curie Memorial Cancer Center, Institute of Oncology, Gliwice Branch, Gliwice, Poland.

View Article

Download full-text PDF

Source
May 2007

[The impact of the extent and time of operation on the survival in patients with differentiated thyroid carcinoma (DTC)].

Endokrynol Pol 2006 Jul-Aug;57(4):347-55

Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Branch Gliwice, Gliwice.

View Article

Download full-text PDF

Source
March 2007

[Completion total thyroidectomy in children with differentiated thyroid cancer].

Endokrynol Pol 2006 Jul-Aug;57(4):356-61

Nuclear Medicine and Endocrine Oncology Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice.

View Article

Download full-text PDF

Source
March 2007

[Evaluation of the therapeutic benefits in relation to the extent of surgery in patients with differentiated thyroid carcinoma].

Endokrynol Pol 2006 Jul-Aug;57(4):362-9

Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice Branch, Gliwice.

View Article

Download full-text PDF

Source
March 2007

[Relapse of differentiated thyroid carcinoma in low-risk patients].

Endokrynol Pol 2006 Jul-Aug;57(4):386-91

Department of Nuclear Medicine and Endocrine Oncology, Comprehensive Cancer Center and M. Sklodowska-Curie Memorial Institute of Oncology, Gliwice Branch, Gliwice.

View Article

Download full-text PDF

Source
March 2007

[Indications for surgery of thyroid cancer based on bioptate molecular examination].

Endokrynol Pol 2006 Jul-Aug;57(4):396-402

Department of Nuclear Medicine and Endocrine Oncology, Comprehensive Cancer Center and M. Sklodowska-Curie Memorial Institute of Oncology, Gliwice Branch, Gliwice.

View Article

Download full-text PDF

Source
March 2007

[Gene expression analysis by DNA microarray in papillary thyroid cancer].

Endokrynol Pol 2005 Sep-Oct;56(5):752-7

Department of Nuclear Medicine and Endocrine Oncology, Clinic of Oncologic Surgery, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland.

View Article

Download full-text PDF

Source
November 2006

Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications.

Cancer Res 2005 Feb;65(4):1587-97

Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-3078DOI Listing
February 2005

[Adenoid cystic carcinoma--a case report].

Otolaryngol Pol 2002 ;56(3):381-4

Centrum Onkologii Instytutu im M.C. Skłodowskiej w Gliwicach.

View Article

Download full-text PDF

Source
October 2002